Sk Biopharmaceuticals Co Ltd (326030.KS) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · South Korea · ISIN KR7326030004
Sk Biopharmaceuticals Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 547.60 bn KRW | 706.74 bn KRW |
| Gross profit | 504.50 bn KRW | 663.84 bn KRW |
| Operating income | 96.34 bn KRW | 203.94 bn KRW |
| EBIT | 83.28 bn KRW | 158.57 bn KRW |
| Net income | 240.74 bn KRW | 266.95 bn KRW |
| Diluted EPS – continuing operations | 3,074.04 KRW | 3,408.75 KRW |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Sk Biopharmaceuticals Co Ltd
SK Biopharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders. The company offers Cenobamate, an anti-seizure medication for the treatment of epilepsy and Solriamfetol medication. It develops Carisbamate that is in Phase 3 trials to treat lennox-gastaut syndrome; Relenopride, which is in Phase 2 clinical trials for treatment of rare neurological disease; SKL24741, which is in Phase 1 clinical trials for the treatment of epilepsy; SKL20540, which is in Phase 1 clinical trials for the treatment of schizophrenia; SKL27969 for treatment of advanced solid tumors; SKL13865 clinical trials to treat attention deficit/hyperactivity disorder; and SKL-PSY that is in Phase 1 clinical trials to treat bipolar disorder. The company was founded in 1993 and is headquartered in Seongnam-si, South Korea. SK Biopharmaceuticals Co., Ltd. operates as a subsidiary of SK Inc.
More stocks
- OHB (OHB.DE)
- Interpump Group SpA (IP.MI)
- GENTEX CORP (GNTX)
- RemeGen Co Ltd (9995.HK)
- TIZA Information Industry Corporation Inc (300209.SZ)
- GEK Terna SA (GEKTERNA.AT)
- UFP INDUSTRIES INC (UFPI)
- Sega Sammy Holdings Inc (6460.T)
- HERC HOLDINGS INC (HRI)
- Bridgepoint Group PLC (BPT.L)
- Hangzhou Binjiang Real Estate Group Co Ltd (002244.SZ)
- SIGNET JEWELERS LTD (SIG)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.